Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Jan-2021
No. of pages: 128
Inquire Before Buying

Parkinson's Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Medications Therapeutics

- Medical Devices Therapeutics

Segment by Application

- Under 40 Years Old

- 40-65 Years Old

- Above 65 Years Old

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- GSK

- Novartis

- Boehringer Ingelheim

- Teva Pharmaceutical

- Abbvie

- Merck

- Akorn

- Kyowa Hakko Kirin Pharma

- Astellas Pharma

- Teva Pharmaceutical

- Abbvie

- F.Hoffmann-La Roche

- H.Lundbeck

- Valeant

- Apokyn

- Orion

- Stada Arzneimittel

- US WorldMeds

Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medications Therapeutics
1.2.3 Medical Devices Therapeutics
1.3 Market by Application
1.3.1 Global Parkinson's Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Therapeutics Market Perspective (2016-2027)
2.2 Parkinson's Disease Therapeutics Growth Trends by Regions
2.2.1 Parkinson's Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Parkinson's Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Parkinson's Disease Therapeutics Industry Dynamic
2.3.1 Parkinson's Disease Therapeutics Market Trends
2.3.2 Parkinson's Disease Therapeutics Market Drivers
2.3.3 Parkinson's Disease Therapeutics Market Challenges
2.3.4 Parkinson's Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Therapeutics Players by Revenue
3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue
3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2020
3.5 Parkinson's Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Parkinson's Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2022-2027)
5 Parkinson's Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Parkinson's Disease Therapeutics Market Size (2016-2027)
6.2 North America Parkinson's Disease Therapeutics Market Size by Type
6.2.1 North America Parkinson's Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Parkinson's Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Parkinson's Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Parkinson's Disease Therapeutics Market Size by Application
6.3.1 North America Parkinson's Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Parkinson's Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Parkinson's Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Parkinson's Disease Therapeutics Market Size by Country
6.4.1 North America Parkinson's Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Parkinson's Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Parkinson's Disease Therapeutics Market Size (2016-2027)
7.2 Europe Parkinson's Disease Therapeutics Market Size by Type
7.2.1 Europe Parkinson's Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Parkinson's Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Parkinson's Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Parkinson's Disease Therapeutics Market Size by Application
7.3.1 Europe Parkinson's Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Parkinson's Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Parkinson's Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Parkinson's Disease Therapeutics Market Size by Country
7.4.1 Europe Parkinson's Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Parkinson's Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Parkinson's Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Parkinson's Disease Therapeutics Market Size by Type
9.2.1 Latin America Parkinson's Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Parkinson's Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Parkinson's Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Parkinson's Disease Therapeutics Market Size by Application
9.3.1 Latin America Parkinson's Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Parkinson's Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Parkinson's Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Parkinson's Disease Therapeutics Market Size by Country
9.4.1 Latin America Parkinson's Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Parkinson's Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Parkinson's Disease Therapeutics Introduction
11.1.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Parkinson's Disease Therapeutics Introduction
11.2.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
11.3.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
11.4.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Abbvie
11.5.1 Abbvie Company Details
11.5.2 Abbvie Business Overview
11.5.3 Abbvie Parkinson's Disease Therapeutics Introduction
11.5.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.5.5 Abbvie Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Parkinson's Disease Therapeutics Introduction
11.6.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Akorn
11.7.1 Akorn Company Details
11.7.2 Akorn Business Overview
11.7.3 Akorn Parkinson's Disease Therapeutics Introduction
11.7.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.7.5 Akorn Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
11.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.9.5 Astellas Pharma Recent Development
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Details
11.10.2 Desitin Arzneimittel Business Overview
11.10.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
11.10.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.10.5 Desitin Arzneimittel Recent Development
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Details
11.11.2 Endo Pharmaceuticals Business Overview
11.11.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
11.11.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.11.5 Endo Pharmaceuticals Recent Development
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Details
11.12.2 F.Hoffmann-La Roche Business Overview
11.12.3 F.Hoffmann-La Roche Parkinson's Disease Therapeutics Introduction
11.12.4 F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.12.5 F.Hoffmann-La Roche Recent Development
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Details
11.13.2 H.Lundbeck Business Overview
11.13.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
11.13.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.13.5 H.Lundbeck Recent Development
11.14 Valeant
11.14.1 Valeant Company Details
11.14.2 Valeant Business Overview
11.14.3 Valeant Parkinson's Disease Therapeutics Introduction
11.14.4 Valeant Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.14.5 Valeant Recent Development
11.15 Apokyn
11.15.1 Apokyn Company Details
11.15.2 Apokyn Business Overview
11.15.3 Apokyn Parkinson's Disease Therapeutics Introduction
11.15.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.15.5 Apokyn Recent Development
11.16 Orion
11.16.1 Orion Company Details
11.16.2 Orion Business Overview
11.16.3 Orion Parkinson's Disease Therapeutics Introduction
11.16.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.16.5 Orion Recent Development
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Details
11.17.2 Stada Arzneimittel Business Overview
11.17.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
11.17.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.17.5 Stada Arzneimittel Recent Development
11.18 US WorldMeds
11.18.1 US WorldMeds Company Details
11.18.2 US WorldMeds Business Overview
11.18.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
11.18.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.18.5 US WorldMeds Recent Development
11.18 Bausch Health
.1 Bausch Health Company Details
.2 Bausch Health Business Overview
.3 Bausch Health Parkinson's Disease Therapeutics Introduction
.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
.5 Bausch Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medications Therapeutics
Table 3. Key Players of Medical Devices Therapeutics
Table 4. Global Parkinson's Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Parkinson's Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Parkinson's Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Parkinson's Disease Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Parkinson's Disease Therapeutics Market Share by Regions (2022-2027)
Table 10. Parkinson's Disease Therapeutics Market Trends
Table 11. Parkinson's Disease Therapeutics Market Drivers
Table 12. Parkinson's Disease Therapeutics Market Challenges
Table 13. Parkinson's Disease Therapeutics Market Restraints
Table 14. Global Parkinson's Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Parkinson's Disease Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2020)
Table 17. Ranking of Global Top Parkinson's Disease Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Parkinson's Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Parkinson's Disease Therapeutics Product Solution and Service
Table 21. Date of Enter into Parkinson's Disease Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Parkinson's Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. GSK Company Details
Table 62. GSK Business Overview
Table 63. GSK Parkinson's Disease Therapeutics Product
Table 64. GSK Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 65. GSK Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Parkinson's Disease Therapeutics Product
Table 69. Novartis Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Boehringer Ingelheim Company Details
Table 72. Boehringer Ingelheim Business Overview
Table 73. Boehringer Ingelheim Parkinson's Disease Therapeutics Product
Table 74. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Boehringer Ingelheim Recent Development
Table 76. Teva Pharmaceutical Company Details
Table 77. Teva Pharmaceutical Business Overview
Table 78. Teva Pharmaceutical Parkinson's Disease Therapeutics Product
Table 79. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Teva Pharmaceutical Recent Development
Table 81. Abbvie Company Details
Table 82. Abbvie Business Overview
Table 83. Abbvie Parkinson's Disease Therapeutics Product
Table 84. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Abbvie Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Parkinson's Disease Therapeutics Product
Table 89. Merck Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Akorn Company Details
Table 92. Akorn Business Overview
Table 93. Akorn Parkinson's Disease Therapeutics Product
Table 94. Akorn Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Akorn Recent Development
Table 96. Kyowa Hakko Kirin Pharma Company Details
Table 97. Kyowa Hakko Kirin Pharma Business Overview
Table 98. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Kyowa Hakko Kirin Pharma Recent Development
Table 100. Astellas Pharma Company Details
Table 101. Astellas Pharma Business Overview
Table 102. Astellas Pharma Parkinson's Disease Therapeutics Product
Table 103. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Astellas Pharma Recent Development
Table 105. Desitin Arzneimittel Company Details
Table 106. Desitin Arzneimittel Business Overview
Table 107. Desitin Arzneimittel Parkinson's Disease Therapeutics Product
Table 108. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Desitin Arzneimittel Recent Development
Table 110. Endo Pharmaceuticals Company Details
Table 111. Endo Pharmaceuticals Business Overview
Table 112. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product
Table 113. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Endo Pharmaceuticals Recent Development
Table 115. F.Hoffmann-La Roche Company Details
Table 116. F.Hoffmann-La Roche Business Overview
Table 117. F.Hoffmann-La Roche Parkinson's Disease Therapeutics Product
Table 118. F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 119. F.Hoffmann-La Roche Recent Development
Table 120. H.Lundbeck Company Details
Table 121. H.Lundbeck Business Overview
Table 122. H.Lundbeck Parkinson's Disease Therapeutics Product
Table 123. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 124. H.Lundbeck Recent Development
Table 125. Valeant Company Details
Table 126. Valeant Business Overview
Table 127. Valeant Parkinson's Disease Therapeutics Product
Table 128. Valeant Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Valeant Recent Development
Table 130. Apokyn Company Details
Table 131. Apokyn Business Overview
Table 132. Apokyn Parkinson's Disease Therapeutics Product
Table 133. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Apokyn Recent Development
Table 135. Orion Company Details
Table 136. Orion Business Overview
Table 137. Orion Parkinson's Disease Therapeutics Product
Table 138. Orion Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 139. Orion Recent Development
Table 140. Stada Arzneimittel Company Details
Table 141. Stada Arzneimittel Business Overview
Table 142. Stada Arzneimittel Parkinson's Disease Therapeutics Product
Table 143. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 144. Stada Arzneimittel Recent Development
Table 145. US WorldMeds Company Details
Table 146. US WorldMeds Business Overview
Table 147. US WorldMeds Parkinson's Disease Therapeutics Product
Table 148. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 149. US WorldMeds Recent Development
Table 150. Bausch Health Company Details
Table 151. Bausch Health Business Overview
Table 152. Bausch Health Parkinson's Disease Therapeutics Product
Table 153. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 154. Bausch Health Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Medications Therapeutics Features
Figure 3. Medical Devices Therapeutics Features
Figure 4. Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Under 40 Years Old Case Studies
Figure 6. 40-65 Years Old Case Studies
Figure 7. Above 65 Years Old Case Studies
Figure 8. Parkinson's Disease Therapeutics Report Years Considered
Figure 9. Global Parkinson's Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Parkinson's Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Parkinson's Disease Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Parkinson's Disease Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Parkinson's Disease Therapeutics Market Share by Players in 2020
Figure 14. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2020
Figure 16. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Region (2016-2027)
Figure 38. China Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 60. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 61. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 63. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2016-2021)
Figure 64. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business
  • Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2021-2027
    Published: 12-Jan-2021        Price: US 3900 Onwards        Pages: 128
    Parkinson's Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - Medications Therapeutics......
  • Global Parkinson's Disease (PD) Drugs Market Outlook 2021
    Published: 24-Dec-2020        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Parkinson's Disease (PD) Drugs market is segmented into - Dopamine Agonist - Monoamine Oxidase Inhibitors......
  • Global Parkinson's Disease Drug Market Outlook 2021
    Published: 22-Dec-2020        Price: US 2900 Onwards        Pages: 115
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Parkinson's Disease Drug market is segmented into - Sinemet-CR - Trastal - Madopar - COMT Inhibit......
  • Rasagiline Tablet Market Insights 2020, Global and Chinese Analysis and Forecast to 2025
    Published: 12-Dec-2020        Price: US 3000 Onwards        Pages: 149
    Rasagiline Tablet Market Insights 2020, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Rasagiline Tablet industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rasagiline Tablet manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2015-2025 global and Chinese Rasagiline Ta......
  • Parkinson's Disease Drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
    Published: 26-Nov-2020        Price: US 2800 Onwards        Pages: 134
    Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by......
  • Global Parkinsons disease Drug Market Research Report 2020
    Published: 03-Nov-2020        Price: US 2900 Onwards        Pages: 115
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Parkinsons disease Drug market is segmented into - Carbidopa/Levodopa - Dopamine Receptor Agonists - MAO......
  • Global and China Parkinson's Disease (PD) Drugs Market Insights, Forecast to 2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 141
    Parkinson's Disease (PD) Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease (PD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Parkinson's......
  • (COVID-19 Version) Global Parkinson's Disease Therapeutics Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 25-Oct-2020        Price: US 3000 Onwards        Pages: 110
    Summary The report forecast global Parkinson's Disease Therapeutics market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Parkinson's Disease Therapeutics industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Pa......
  • Global and Japan Parkinson's Disease Drug Market Insights, Forecast to 2026
    Published: 21-Oct-2020        Price: US 3900 Onwards        Pages: 148
    Parkinson's Disease Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Parkinson's Disease Dru......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs